This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
influenza virus | 204 |
respiratory syndrome | 180 |
immune responses | 176 |
immune response | 171 |
porcine reproductive | 168 |
additional file | 154 |
nk cells | 152 |
syndrome virus | 143 |
alpha toxin | 130 |
epithelial cells | 125 |
class i | 123 |
newcastle disease | 116 |
virus infection | 114 |
mhc class | 113 |
disease virus | 111 |
avian influenza | 108 |
infected pigs | 90 |
innate immune | 90 |
vero cells | 79 |
porcine epidemic | 74 |
clinical signs | 71 |
prrsv infection | 71 |
viral rna | 69 |
significantly higher | 68 |
diarrhea virus | 68 |
epidemic diarrhea | 68 |
infected cells | 67 |
bnp dams | 65 |
gene expression | 65 |
day pi | 63 |
ns protein | 63 |
subtilis spores | 61 |
control group | 58 |
virus replication | 56 |
cell subsets | 54 |
expression levels | 53 |
nkp high | 53 |
respiratory disease | 52 |
bvd vaccinated | 50 |
performed using | 50 |
dendritic cells | 50 |
clostridium perfringens | 49 |
tissue samples | 49 |
previously described | 48 |
type i | 48 |
influenza viruses | 47 |
infectious peritonitis | 46 |
western blotting | 46 |
vet res | 45 |
bridge hosts | 45 |
feline infectious | 45 |
time points | 45 |
highly pathogenic | 44 |
present study | 44 |
virus strains | 42 |
high nk | 42 |
monoclonal antibodies | 42 |
cord uid | 41 |
res doi | 41 |
two groups | 41 |
immune system | 41 |
doc id | 41 |
negative control | 40 |
serum samples | 40 |
infectious bronchitis | 40 |
respiratory tract | 40 |
viral loads | 40 |
virus shedding | 39 |
swine influenza | 39 |
feline coronavirus | 39 |
viral infections | 39 |
room temperature | 39 |
united states | 38 |
three times | 37 |
neutralizing antibodies | 37 |
atlantic salmon | 37 |
significant differences | 37 |
nkp nk | 37 |
porcine circovirus | 37 |
host immune | 36 |
viral infection | 36 |
applied biosystems | 36 |
peripheral blood | 36 |
pedv entry | 36 |
treatment groups | 36 |
gds strains | 35 |
bridge host | 35 |
infected group | 35 |
cell culture | 34 |
western blot | 34 |
total rna | 34 |
inflammatory cytokines | 34 |
viral replication | 33 |
experimental infection | 33 |
significantly lower | 33 |
significant difference | 33 |
authors declare | 33 |
without fip | 33 |
syncytial virus | 32 |
body weight | 32 |
life technologies | 32 |
adaptive immune | 32 |
respiratory syncytial | 32 |
mononuclear cells | 32 |
necrotic enteritis | 32 |
antibody responses | 32 |
competing interests | 32 |
virus strain | 31 |
disease viruses | 31 |
results showed | 31 |
cell responses | 31 |
time point | 31 |
flow cytometry | 31 |
days post | 31 |
tcid ml | 31 |
mab igg | 31 |
pathogenic avian | 31 |
splenic nkp | 30 |
amino acid | 30 |
apmv serotypes | 30 |
polymerase chain | 30 |
immune cells | 30 |
relative risk | 30 |
mouth disease | 30 |
chain reaction | 30 |
bronchitis virus | 30 |
exhibition swine | 30 |
well plates | 30 |
mediated endocytosis | 30 |
bovine respiratory | 30 |
described previously | 29 |
infected cats | 29 |
authors read | 29 |
previous study | 29 |
antibody response | 29 |
antiviral activity | 29 |
vaccinated non | 28 |
final manuscript | 28 |
natural killer | 28 |
swine fever | 28 |
tw i | 28 |
faecal samples | 28 |
wild birds | 28 |
alveolar macrophages | 28 |
lymph nodes | 28 |
nasal swabs | 27 |
previous studies | 27 |
dpv dpc | 27 |
cell proliferation | 27 |
reverse transcription | 26 |
cytokine production | 26 |
innate immunity | 26 |
small intestine | 26 |
risk factors | 26 |
boost vaccination | 26 |
mycoplasma hyopneumoniae | 26 |
haemonchus contortus | 25 |
i interferon | 25 |
type ibv | 25 |
vaccinated pigs | 25 |
time pcr | 25 |
vaccinated dams | 25 |
control pigs | 24 |
culture medium | 24 |
avian paramyxovirus | 24 |
salmo salar | 24 |
bacillus subtilis | 24 |
infected animals | 24 |
circovirus type | 24 |
infected groups | 24 |
vaccine development | 23 |
alloantibody binding | 23 |
lawsonia intracellularis | 23 |
like receptor | 23 |
important role | 23 |
regulated genes | 23 |
specific group | 23 |
heterologous prime | 23 |
goat anti | 23 |
dynamin ii | 23 |
blood mononuclear | 23 |
stranded rna | 22 |
intestinal loop | 22 |
blood nkp | 22 |
mdbk cells | 22 |
mouse enteroids | 22 |
treatment group | 22 |
bovine viral | 22 |
blood samples | 21 |
maintenance host | 21 |
proinflammatory cytokines | 21 |
defective interfering | 21 |
cell surface | 21 |
veterinary medicine | 20 |
direct contact | 20 |
amino acids | 20 |
animal health | 20 |
cats without | 20 |
pedv strains | 20 |
sav rna | 20 |
current study | 20 |
terminal domain | 20 |
nasal turbinates | 20 |
host proteins | 20 |
lipid raft | 20 |
invasion rates | 20 |
passively immunized | 20 |
cells showed | 20 |
bd biosciences | 20 |
cl protease | 20 |
structural proteins | 20 |
supplementary material | 20 |
economic losses | 20 |
statistically significant | 20 |
ovo vaccination | 20 |
intestinal epithelial | 20 |
enter cells | 19 |
laiv com | 19 |
class ii | 19 |
specific antibody | 19 |
ciliated cells | 19 |
genetic diversity | 19 |
hpai risk | 19 |
cell viability | 19 |
dependent manner | 19 |
cell line | 19 |
escherichia coli | 19 |
protective immunity | 19 |
antibody levels | 19 |
hi titers | 19 |
experimentally infected | 19 |
balf samples | 19 |
virus titers | 19 |
respiratory epithelial | 19 |
terminal fragment | 19 |
bovine serum | 19 |
per well | 19 |
disease complex | 19 |
cryptosporidium species | 19 |
immunodeficiency virus | 19 |
fecv ucd | 18 |
virus challenge | 18 |
significantly increased | 18 |
higher levels | 18 |
pcr products | 18 |
cell cycle | 18 |
inflammatory response | 18 |
classical swine | 18 |
porcine respiratory | 18 |
virus infections | 18 |
cell subset | 18 |
sav controls | 18 |
three different | 18 |
lymphoid organs | 18 |
influenza infection | 18 |
cell population | 18 |
es proteins | 18 |
igg group | 18 |
viral particles | 18 |
sav shedders | 18 |
intracellularis infection | 18 |
animal care | 18 |
purified tadv | 18 |
native alpha | 17 |
viral diarrhea | 17 |
gar strains | 17 |
virus type | 17 |
rna virus | 17 |
bnp calves | 17 |
also observed | 17 |
thermo fisher | 17 |
based vaccine | 17 |
molecular epidemiology | 17 |
necrohemorrhagic enteritis | 17 |
viruses isolated | 17 |
fever virus | 17 |
proteomic analysis | 17 |
cd cd | 17 |
aut com | 17 |
clinical disease | 17 |
sav control | 17 |
signalling pathway | 17 |
challenge infection | 17 |
pbs containing | 17 |
bvdv bhv | 17 |
cleavage site | 17 |
lung lesions | 17 |
loop model | 17 |
virus isolated | 17 |
epithelial barrier | 16 |
virus entry | 16 |
mg kg | 16 |
skeletal muscle | 16 |
viral titers | 16 |
mouse anti | 16 |
target host | 16 |
rna levels | 16 |
vac cha | 16 |
vascular areas | 16 |
leucine codon | 16 |
vp genes | 16 |
mhf infection | 16 |
passive immunization | 16 |
virus particles | 16 |
serial dilutions | 16 |
infectious agents | 16 |
structural protein | 16 |
several studies | 16 |
rna viruses | 16 |
samples collected | 16 |
north american | 16 |
mouse igg | 16 |
airway epithelial | 16 |
monoclonal antibody | 16 |
proliferative enteropathy | 16 |
complete genome | 16 |
myocardial necrosis | 16 |
two different | 16 |
calculated using | 16 |
specific immune | 16 |
specific antibodies | 16 |
post infection | 16 |
mrna levels | 16 |
springer nature | 15 |
nature remains | 15 |
canine influenza | 15 |
viral load | 15 |
iav infection | 15 |
bovine herpesvirus | 15 |
laiv none | 15 |
mediated immune | 15 |
bovine necrohemorrhagic | 15 |
genbank accession | 15 |
perfringens alpha | 15 |
remains neutral | 15 |
disease ecology | 15 |
protective immune | 15 |
molecular characterization | 15 |
chicken genome | 15 |
open access | 15 |
jurisdictional claims | 15 |
adaptive immunity | 15 |
subtilis spore | 15 |
protective efficacy | 15 |
control cats | 15 |
fecv rm | 15 |
gas gangrene | 15 |
gp gp | 15 |
immune signalling | 15 |
nk cell | 15 |
type ii | 15 |
institutional affiliations | 15 |
vaccine delivery | 15 |
published maps | 15 |
seeder pigs | 15 |
lymphoid tissues | 15 |
egg production | 15 |
pedv clpro | 15 |
challenge strains | 15 |
kindly provided | 15 |
presenting cells | 14 |
target population | 14 |
histopathological changes | 14 |
like particles | 14 |
real time | 14 |
alloantibody levels | 14 |
chicken mdm | 14 |
even though | 14 |
hcesp stimuli | 14 |
herpes simplex | 14 |
broiler chickens | 14 |
tumor necrosis | 14 |
analyzed using | 14 |
transmission function | 14 |
results indicate | 14 |
neonatal pancytopenia | 14 |
sialic acid | 14 |
buffered saline | 14 |
time rt | 14 |
necrosis factor | 14 |
immune complexes | 14 |
fisher scientific | 14 |
provide protection | 14 |
cell response | 14 |
pg ml | 14 |
target cells | 14 |
group showed | 14 |
may also | 14 |
washed three | 14 |
interstitial pneumonia | 14 |
immune evasion | 14 |
human influenza | 14 |
genome sequence | 14 |
note springer | 14 |
grazing ducks | 14 |
antiviral response | 14 |
avian species | 14 |
secreting cells | 14 |
peritonitis virus | 14 |
cat jhw | 14 |
differential expression | 14 |
lymph node | 14 |
enteric diseases | 14 |
acute myocardial | 14 |
total protein | 14 |
endothelial cells | 14 |
influenza vaccine | 14 |
gds strain | 14 |
three viruses | 14 |
different species | 13 |
plga nps | 13 |
vaccine antigens | 13 |
com com | 13 |
mm tris | 13 |
peer review | 13 |
indirect contact | 13 |
statistical analysis | 13 |
antibody titers | 13 |
methionine codon | 13 |
vsv vrp | 13 |
reverse transcriptase | 13 |
virus vaccine | 13 |
ms ms | 13 |
salmonid alphavirus | 13 |
lung tissues | 13 |
sav infection | 13 |
human nk | 13 |
way anova | 13 |
irrelevant mab | 13 |
ng ml | 13 |
naturally infected | 13 |
specific primers | 13 |
serum antibody | 13 |
mdck cells | 13 |
viral proteins | 13 |
paramyxovirus type | 13 |
human immunodeficiency | 13 |
binding protein | 13 |
anthropogenic factors | 13 |
density gradient | 13 |
analysed using | 13 |
dendritic cell | 13 |
high density | 13 |
graphpad prism | 13 |
porcine alveolar | 13 |
regulated deg | 13 |
measured using | 13 |
mass spectrometry | 13 |
recent study | 13 |
inactivated vaccine | 13 |
field conditions | 13 |
vp gene | 13 |
i alleles | 13 |
online submission | 13 |
commercially available | 13 |
based vaccines | 13 |
late endosomes | 13 |
host cells | 13 |
target hosts | 13 |
convenient online | 13 |
immunized cats | 13 |
pedv rna | 13 |
bovine neonatal | 13 |
prv infection | 13 |
sus scrofa | 13 |
infectious diseases | 13 |
stimulated genes | 13 |
thorough peer | 13 |
fmdv isolates | 13 |
different nk | 13 |
infected mdm | 13 |
neutralizing antibody | 13 |
pancreas disease | 13 |
monocytes macrophages | 13 |
nitric oxide | 12 |
cd cells | 12 |
mice treated | 12 |
bal cells | 12 |
also found | 12 |
results show | 12 |
bronchiolar areas | 12 |
false discovery | 12 |
copy numbers | 12 |
lymphocyte counts | 12 |
low levels | 12 |
final concentration | 12 |
porcine viral | 12 |
cell populations | 12 |
oral vaccines | 12 |
additional files | 12 |
late co | 12 |
master mix | 12 |
pigs vaccinated | 12 |
intracellularis antigen | 12 |
use committee | 12 |
aut aut | 12 |
envelope proteins | 12 |
defined nk | 12 |
reference interval | 12 |
target populations | 12 |
prrsv olot | 12 |
oil vaccine | 12 |
antiviral responses | 12 |
cells infected | 12 |
weeks old | 12 |
spike protein | 12 |
simplex virus | 12 |
virus stock | 12 |
pedv iga | 12 |
better understanding | 12 |
rabbit anti | 12 |
epithelial cell | 12 |
per year | 12 |
old calves | 12 |
cellular immune | 12 |
cell types | 12 |
determined using | 12 |
antigenic differences | 12 |
mg ml | 12 |
inactivated vaccines | 12 |
host responses | 12 |
results indicated | 12 |
tissue culture | 12 |
recipient cats | 12 |
significantly different | 12 |
serum dilution | 12 |
taken together | 12 |
invasion efficiency | 12 |
post inoculation | 12 |
conjugated anti | 12 |
infected hamsters | 12 |
spf cats | 12 |
diarrhoea virus | 12 |
results suggest | 12 |
vaccine adjuvants | 12 |
cells via | 11 |
infectious dose | 11 |
rna detection | 11 |
killer cell | 11 |
virus vaccines | 11 |
protein kinase | 11 |
animal welfare | 11 |
distilled water | 11 |
mrna expression | 11 |
public health | 11 |
serotype i | 11 |
chicken eggs | 11 |
pathogen transmission | 11 |
vaccine candidates | 11 |
reproductive system | 11 |
toxin activity | 11 |
actinobacillus pleuropneumoniae | 11 |
see additional | 11 |
control animals | 11 |
hi assay | 11 |
wild bird | 11 |
infection studies | 11 |
recent studies | 11 |
widely used | 11 |
primary antibodies | 11 |
rna extraction | 11 |
viral clearance | 11 |
nucleocapsid protein | 11 |
institutional animal | 11 |
clinical outcome | 11 |
com pigs | 11 |
maintenance function | 11 |
poultry products | 11 |
cha pigs | 11 |
flow cytometric | 11 |
significantly inhibited | 11 |
cd high | 11 |
pedv infection | 11 |
live vaccine | 11 |
high levels | 11 |
host populations | 11 |
respiratory diseases | 11 |
culture system | 11 |
virus isolation | 11 |
necrosis virus | 11 |
vaccinated animals | 11 |
two cats | 11 |
weight gain | 11 |
cd antibody | 11 |
day post | 11 |
differentiated respiratory | 11 |
determine whether | 11 |
chicken macrophages | 11 |
cell lines | 11 |
low pathogenic | 11 |
infectious disease | 11 |
bacterial pathogens | 11 |
host defense | 11 |
vesicular stomatitis | 11 |
fresh dmem | 11 |
specific pathogen | 11 |
host systems | 11 |
nucleic acid | 11 |
stomatitis virus | 11 |
veterinary vaccines | 11 |
infected fish | 11 |
specific igg | 11 |
cell apoptosis | 11 |
secondary antibody | 11 |
expression analysis | 10 |
human health | 10 |
viral shedding | 10 |
medium containing | 10 |
dc macrophage | 10 |
lung parenchyma | 10 |
second wave | 10 |
discovery rate | 10 |
nkp expression | 10 |
domestic ducks | 10 |
bursal disease | 10 |
electronic supplementary | 10 |
domestic birds | 10 |
per ml | 10 |
standard deviation | 10 |
enrichment analyses | 10 |
porcine parvovirus | 10 |
authors thank | 10 |
i ifn | 10 |
viral antigen | 10 |
virus ns | 10 |
native chickens | 10 |
blood cells | 10 |
vrp expressing | 10 |
infected chickens | 10 |
three animals | 10 |
cells cultured | 10 |
rat anti | 10 |
apical surface | 10 |
cryptosporidium parvum | 10 |
viral strains | 10 |
life cycle | 10 |
relative copy | 10 |
uninfected control | 10 |
cell extracts | 10 |
type strain | 10 |
viral diseases | 10 |
described elsewhere | 10 |
persistent infection | 10 |
three groups | 10 |
cell lysates | 10 |
vaccine vector | 10 |
alveolar areas | 10 |
considered positive | 10 |
infected calves | 10 |
responses induced | 10 |
gp ecto | 10 |
prrsv envelope | 10 |
swine industry | 10 |
like receptors | 10 |
three virus | 10 |
female reproductive | 10 |
gfp nsp | 10 |
agilent technologies | 10 |
different concentrations | 10 |
commonly used | 10 |
pcr product | 10 |
early endosomes | 10 |
late group | 10 |
body temperature | 10 |
different lung | 10 |
analysis using | 10 |
biomed central | 10 |
contains supplementary | 10 |
plasmacytoid dendritic | 10 |
derived dendritic | 10 |
delivery systems | 10 |
highly virulent | 10 |
mycoplasma haemofelis | 10 |
live virus | 10 |
cd expression | 10 |
porcine nk | 10 |
porcine rotavirus | 10 |
mice infected | 10 |
platelet aggregation | 10 |
fcov rna | 10 |
online version | 10 |
challenge group | 10 |
control groups | 10 |
nucleotide sequence | 10 |
next manuscript | 10 |
infectious bursal | 10 |
cytolytic activity | 10 |
mean values | 10 |
authorized users | 10 |
porcine cd | 10 |
viral antigens | 10 |
heart tissue | 10 |
ct value | 10 |
similar results | 10 |
humoral immune | 10 |
host factors | 10 |
mechanisms involved | 10 |
acute phase | 10 |
challenged pigs | 10 |
inhibitory effects | 10 |
ffu ml | 10 |
different time | 10 |
animal experiments | 10 |
collagen alpha | 10 |
cytokine levels | 10 |
genome segments | 10 |
mdbk cell | 9 |
ii cells | 9 |
washed twice | 9 |
website views | 9 |
virus js | 9 |
innate antiviral | 9 |
fecal samples | 9 |
lysis buffer | 9 |
single cell | 9 |
supplementary information | 9 |
oral vaccination | 9 |
transmissible gastroenteritis | 9 |
also used | 9 |
porcine proliferative | 9 |
closely related | 9 |
pseudorabies virus | 9 |
pbs group | 9 |
first detected | 9 |
virulent newcastle | 9 |
negative controls | 9 |
cell cultures | 9 |
miltenyi biotec | 9 |
ampk signalling | 9 |
positive control | 9 |
potential bridge | 9 |
heavy chain | 9 |
risk factor | 9 |
vaccine induced | 9 |
bilirubin concentrations | 9 |
cell debris | 9 |
african swine | 9 |
early stage | 9 |
suckling pigs | 9 |
maximum visibility | 9 |
defective viral | 9 |
pcr analysis | 9 |
hamsters infected | 9 |
citations maximum | 9 |
bvd vaccine | 9 |
blot analysis | 9 |
rat igg | 9 |
previous reports | 9 |
fosters wider | 9 |
recent years | 9 |
complex data | 9 |
receptor binding | 9 |
alveolar epithelial | 9 |
variant strains | 9 |
pedv igg | 9 |
significantly reduced | 9 |
chitosan nps | 9 |
esterase activity | 9 |
cytokine response | 9 |
lung compartments | 9 |
clinical symptoms | 9 |
acute respiratory | 9 |
including large | 9 |
homologous challenge | 9 |
increased citations | 9 |
data analysis | 9 |
severe acute | 9 |
lower respiratory | 9 |
information accompanies | 9 |
salmonella enterica | 9 |
shuttle vector | 9 |
wider collaboration | 9 |
quantitative rt | 9 |
pathogen free | 9 |
cellular proteins | 9 |
sequence analysis | 9 |
new zealand | 9 |
grand island | 9 |
avian paramyxoviruses | 9 |
hi test | 9 |
three technologies | 9 |
animals infected | 9 |
weight loss | 9 |
go terms | 9 |
plasma transfusion | 9 |
antagonistic ability | 9 |
feline coronaviruses | 9 |
one cat | 9 |
many studies | 9 |
tissue damage | 9 |
poultry industry | 9 |
inflammatory cytokine | 9 |
plasma membrane | 9 |
killer cells | 9 |
poultry production | 9 |
control measures | 9 |
inflammatory mediators | 9 |
com aut | 9 |
treated tadv | 9 |
research data | 9 |
blotting assay | 9 |
views per | 9 |
mm edta | 9 |
virus clearance | 9 |
graphpad software | 9 |
basal cells | 9 |
hemoplasma species | 9 |
wiv treatment | 9 |
high level | 9 |
virus rna | 9 |
fusion protein | 9 |
cell monolayers | 9 |
alexa fluor | 9 |
necrotic lesions | 9 |
th responses | 9 |
cytokine receptor | 9 |
gold open | 9 |
differentially expressed | 9 |
enteric coronavirus | 9 |
host innate | 9 |
primers used | 9 |
least one | 9 |
data types | 9 |
normal rat | 9 |
xx xx | 9 |
pathological lesions | 9 |
disease control | 9 |
infectious pathogens | 9 |
san diego | 9 |
chickens immunized | 9 |
pcr assay | 9 |
pigs receiving | 9 |
coronavirus infection | 9 |
one week | 9 |
fecv infection | 9 |
cats showed | 9 |
three independent | 9 |
rapid publication | 8 |
vaccine production | 8 |
antigen uptake | 8 |
mucosal iga | 8 |
healthy cats | 8 |
virus porcine | 8 |
lineage specific | 8 |
activated cd | 8 |
swabs collected | 8 |
antiviral immunity | 8 |
poultry farms | 8 |
protein expression | 8 |
antigen presenting | 8 |
vaccination strategy | 8 |
immune organs | 8 |
chemokine receptor | 8 |
purified virions | 8 |
secondary antibodies | 8 |
lung viral | 8 |
cellular proliferation | 8 |
candidatus mycoplasma | 8 |
second transfection | 8 |
infectious virus | 8 |
oral vaccine | 8 |
viral genome | 8 |
accession number | 8 |
geometric mean | 8 |
perfringens type | 8 |
avian leukosis | 8 |
bln tissues | 8 |
pbs control | 8 |
hcesp igg | 8 |
genes identified | 8 |
il i | 8 |
cryptosporidium infection | 8 |
protective effect | 8 |
host population | 8 |
i haplotypes | 8 |
critical role | 8 |
infected enteroids | 8 |
host response | 8 |
absolute number | 8 |
histopathological lesions | 8 |
blotting analysis | 8 |
serum antibodies | 8 |
respiratory pathogens | 8 |
chlorocebus sabaeus | 8 |
one pathogen | 8 |
canine parvovirus | 8 |
experienced researchers | 8 |
immune serum | 8 |
spf chickens | 8 |
per cell | 8 |
independent experiments | 8 |
cd low | 8 |
another study | 8 |
human respiratory | 8 |
igg antibodies | 8 |
seq data | 8 |
antibiotic use | 8 |
inhibits pedv | 8 |
pcr using | 8 |
paternally inherited | 8 |
ml penicillin | 8 |
host gene | 8 |
vaccine strains | 8 |
cha group | 8 |
deep sequencing | 8 |
experimental groups | 8 |
transcription unit | 8 |
pigs compared | 8 |
pcr results | 8 |
binding energy | 8 |
avian infectious | 8 |
pdc activation | 8 |
fipv replication | 8 |
iga antibodies | 8 |
endocytic pathways | 8 |
commercial vaccines | 8 |
recovered cats | 8 |
viral interference | 8 |
virus induces | 8 |
inoculated groups | 8 |
three cats | 8 |
heterologous aut | 8 |
red blood | 8 |
gel electrophoresis | 8 |
kag vaccine | 8 |
ms analysis | 8 |
muscle inflammation | 8 |
significant decrease | 8 |
fetal bovine | 8 |
pedv replication | 8 |
rna samples | 8 |
virus neutralizing | 8 |
small intestinal | 8 |
full advantage | 8 |
civ infection | 8 |
fip group | 8 |
infectious contacts | 8 |
growing pigs | 8 |
swine exhibitions | 8 |
vaccinated bnp | 8 |
pcr system | 8 |
histopathological evaluation | 8 |
ml hcesps | 8 |
deficient strain | 8 |
economically important | 8 |
buffered formalin | 8 |
faecal virus | 8 |
sample collection | 8 |
membrane fusion | 8 |
tne buffer | 8 |
lethal influenza | 8 |
human population | 8 |
signalling pathways | 8 |
thermo scientific | 8 |
genetic differences | 8 |
economic impact | 8 |
take full | 8 |
commercial inactivated | 8 |
bone marrow | 8 |
feline enteric | 8 |
essential medium | 8 |
lung tissue | 8 |
nucleotide sequences | 8 |
pigs porcine | 8 |
white leghorn | 8 |
fcov antigen | 8 |
protein concentrations | 8 |
low ph | 8 |
iu ml | 8 |
national university | 8 |
following vaccination | 8 |
bvd vaccination | 8 |
activate pdc | 8 |
maintenance hosts | 8 |
whether pedv | 8 |
may contribute | 8 |
haemorrhagic enteritis | 8 |
egg yolk | 8 |
cut lung | 8 |
signaling pathway | 8 |
differentiated epithelial | 8 |
i haplotype | 8 |
cell counts | 8 |
host species | 8 |
feline hemoplasma | 8 |
agricultural university | 8 |
virus isolates | 8 |
infected mice | 7 |
ad libitum | 7 |
approval number | 7 |
terms related | 7 |
bnp within | 7 |
parainfluenza virus | 7 |
old animals | 7 |
goblet cells | 7 |
virus titer | 7 |
mucosal immune | 7 |
gastroenteritis virus | 7 |
contact birds | 7 |
final concentrations | 7 |
standard curve | 7 |
using graphpad | 7 |
provide information | 7 |
early group | 7 |
genetic analysis | 7 |
two viruses | 7 |
microscopic lesions | 7 |
vaccination strategies | 7 |
ii pneumocytes | 7 |
early co | 7 |
better understand | 7 |
stat pathway | 7 |
multiple comparisons | 7 |
vaccine strain | 7 |
respiratory coronavirus | 7 |
quantitative pcr | 7 |
opsonising antibodies | 7 |
cellular localization | 7 |
vaccine efficacy | 7 |
ptov strains | 7 |
swine disease | 7 |
intracellular staining | 7 |
also present | 7 |
lung slices | 7 |
disease development | 7 |
recognised genes | 7 |
extracellular part | 7 |
first step | 7 |
rna binding | 7 |
interfering particles | 7 |
qpcr assay | 7 |
also identified | 7 |
cycle threshold | 7 |
inactivated virus | 7 |
horseradish peroxidase | 7 |
enveloped viruses | 7 |
calves born | 7 |
gross lesions | 7 |
roche diagnostics | 7 |
binding domain | 7 |
serum sample | 7 |
major histocompatibility | 7 |
prrsv gp | 7 |
virulent strains | 7 |
binding sites | 7 |
positive samples | 7 |
gradient centrifugation | 7 |
tissue sample | 7 |
gene specific | 7 |
phosphate buffered | 7 |
fluorescence intensity | 7 |
also significantly | 7 |
group compared | 7 |
highly activated | 7 |
mucosal immunity | 7 |
primer sequences | 7 |
vaccine candidate | 7 |
pigs infected | 7 |
vectored vaccines | 7 |
cell activation | 7 |
fold higher | 7 |
different cell | 7 |
wiv groups | 7 |
live attenuated | 7 |
three mice | 7 |
large number | 7 |
high cd | 7 |
oligoadenylate synthetase | 7 |
target genes | 7 |
infected cell | 7 |
also thank | 7 |
sars coronavirus | 7 |
san jose | 7 |
double stranded | 7 |
i genes | 7 |
signal transduction | 7 |
peak viremia | 7 |
producing cells | 7 |
local immune | 7 |
mhf pcr | 7 |
standard error | 7 |
significant pathways | 7 |
complete protection | 7 |
epidemic diarrhoea | 7 |
receptor cxcr | 7 |
macrophage network | 7 |
ex vivo | 7 |
major cities | 7 |
live bird | 7 |
accession numbers | 7 |
respiratory problems | 7 |
previous work | 7 |
prv rna | 7 |
cells treated | 7 |
groups showed | 7 |
piscine orthoreovirus | 7 |
dominant negative | 7 |
feline hemoplasmas | 7 |
fluorescence microscope | 7 |
lipid rafts | 7 |
nh cl | 7 |
viral disease | 7 |
pedv particles | 7 |
natural cytotoxicity | 7 |
tight junctions | 7 |
remains unclear | 7 |
may provide | 7 |
maintenance community | 7 |
like particle | 7 |
bronchiolar epithelial | 7 |
bronchoalveolar lavage | 7 |
commercial poultry | 7 |
histological lesions | 7 |
antibody titer | 7 |
binding proteins | 7 |
porcine intestinal | 7 |
using qrt | 7 |
groups compared | 7 |
technical assistance | 7 |
southeast asia | 7 |
recent advances | 7 |
complex interactions | 7 |
phage display | 7 |
lymphocyte subsets | 7 |
citrate buffer | 7 |
conjugated goat | 7 |
calf serum | 7 |
enterica serovar | 7 |
significant reduction | 7 |
open reading | 7 |
systemic immune | 7 |
fighting cocks | 7 |
cells per | 7 |
different ages | 7 |
leghorn chickens | 7 |
different strategies | 7 |
highly conserved | 7 |
clpro activity | 7 |
production compared | 7 |
airway epithelium | 7 |
bronchointerstitial pneumonia | 7 |
related genes | 7 |
dna polymerase | 7 |
dmem containing | 7 |
cd cell | 7 |
study period | 7 |
host interactions | 7 |
respiratory viruses | 7 |
inflammatory responses | 7 |
enteroid cells | 7 |
igg antibody | 7 |
serum dilutions | 7 |
facs buffer | 7 |
lung samples | 7 |
epidemiological studies | 7 |
future studies | 7 |
antibody titres | 7 |
cytometry analysis | 7 |
donor cats | 7 |
economic loss | 7 |
control strategies | 7 |
bacterial infection | 7 |
unequal variance | 7 |
prrsv proteins | 7 |
bsc cells | 7 |
porcine torovirus | 7 |
cells using | 7 |
cells grown | 7 |
current status | 7 |
farmed atlantic | 7 |
total volume | 7 |
key role | 7 |
rna level | 7 |
leukosis virus | 7 |
early stages | 7 |
differentially regulated | 7 |
enhance antigen | 7 |
american strain | 7 |
mm nacl | 7 |
infected flock | 7 |
reference strain | 7 |
nasal turbinate | 7 |
cytometric analysis | 7 |
full length | 6 |
fold dilutions | 6 |
nkp cells | 6 |
agricultural exhibitions | 6 |
i typing | 6 |
severe disease | 6 |
inoculated oronasally | 6 |
naturally occurring | 6 |
loop experiments | 6 |
derived macrophages | 6 |
two tailed | 6 |
peak bacteremia | 6 |
coding sequences | 6 |
potential vaccine | 6 |
protein gene | 6 |
also known | 6 |
acute infection | 6 |
bronchial epithelial | 6 |
repeated outbreaks | 6 |
cryptosporidium spp | 6 |
differences among | 6 |
vaccination protocols | 6 |
pig farms | 6 |
secondary bacterial | 6 |
calves immunized | 6 |
diarrhea among | 6 |
layer chickens | 6 |
access correspondence | 6 |
total lung | 6 |
showed higher | 6 |
rainbow trout | 6 |
higher viral | 6 |
cold pbs | 6 |
dairy cattle | 6 |
veal calves | 6 |
infected heart | 6 |
bars indicate | 6 |
dengue virus | 6 |
maternal antibodies | 6 |
strains comprising | 6 |
significantly induced | 6 |
tomatidine inhibits | 6 |
means control | 6 |
th cells | 6 |
pyrosequencing assay | 6 |
findings suggest | 6 |
respiratory epithelium | 6 |
using two | 6 |
chicken ifn | 6 |
st array | 6 |
cell infiltration | 6 |
immune mechanisms | 6 |
perfringens strains | 6 |
significance reached | 6 |
biological replicates | 6 |
turkey adenovirus | 6 |
humidified atmosphere | 6 |
conjugated mouse | 6 |
primary antibody | 6 |
perfringens supernatant | 6 |
multiple comparison | 6 |
individual pigs | 6 |
different levels | 6 |
pattern recognition | 6 |
staphylococcus aureus | 6 |
also showed | 6 |
statistical analyses | 6 |
southern china | 6 |
effector cells | 6 |
cell type | 6 |
com treatment | 6 |
recognition receptors | 6 |
fip cats | 6 |
monocyte macrophage | 6 |
ct values | 6 |
dna virus | 6 |
simple method | 6 |
culture media | 6 |
natural route | 6 |
important roles | 6 |
expressed genes | 6 |
muench method | 6 |
increased expression | 6 |
domestic cats | 6 |
swine population | 6 |
antigenic diversity | 6 |
challenge virus | 6 |
capsid protein | 6 |
hemorrhagic enteritis | 6 |
inhibit pedv | 6 |
host defence | 6 |
optical density | 6 |
oral immunization | 6 |
week old | 6 |
turkeys infected | 6 |
described earlier | 6 |
nucleotide identity | 6 |
genome sequences | 6 |
lower compared | 6 |
pedv cl | 6 |
generation sequencing | 6 |
tcid cell | 6 |
negative mutants | 6 |
induced enteric | 6 |
blood monocytes | 6 |
ml streptomycin | 6 |
different strains | 6 |
ctrl means | 6 |
respiratory system | 6 |
weeks pi | 6 |
th immune | 6 |
rna genome | 6 |
local tissues | 6 |
total alloantibody | 6 |
mice challenged | 6 |
receptor signalling | 6 |
first outbreak | 6 |
human activities | 6 |
first transfection | 6 |
bird markets | 6 |
iga antibody | 6 |
virus stocks | 6 |
nucleic acids | 6 |
prv cohabitants | 6 |
infection model | 6 |
molecular weight | 6 |
i allele | 6 |
anova followed | 6 |
heterologous virus | 6 |
fold change | 6 |
abd serotec | 6 |
old piglets | 6 |
host cell | 6 |
highway junction | 6 |
nanjing agricultural | 6 |
except apmv | 6 |
subunit vaccines | 6 |
randomly assigned | 6 |
viral pathogens | 6 |
new york | 6 |
modified live | 6 |
infectious pancreatic | 6 |
analysis revealed | 6 |
vitro culture | 6 |
activated state | 6 |
highly expressed | 6 |
humoral responses | 6 |
sanger sequencing | 6 |
results demonstrated | 6 |
pedv invasion | 6 |
significance threshold | 6 |
cytokine signaling | 6 |
randomly selected | 6 |
scale bars | 6 |
equal volume | 6 |
subtype iiaa | 6 |
blood cell | 6 |
pathological changes | 6 |
zoonotic transmission | 6 |
pronounced immune | 6 |
pulmonary parenchyma | 6 |
fcov infection | 6 |
hydrogen bonds | 6 |
weeks post | 6 |
viral diarrhoea | 6 |
using different | 6 |
days later | 6 |
potential role | 6 |
histocompatibility complex | 6 |
liquid chromatography | 6 |
freshly isolated | 6 |
cytopathic effect | 6 |
statistical significance | 6 |
two subsets | 6 |
hemagglutination inhibition | 6 |
cycle sequencing | 6 |
well plate | 6 |
pigs remained | 6 |
important viral | 6 |
antigenic drift | 6 |
viral protein | 6 |
molecular analysis | 6 |
total number | 6 |
cell adhesion | 6 |
stranded dna | 6 |
persistently infected | 6 |
oral delivery | 6 |
induced necrosis | 6 |
pcr positive | 6 |
following challenge | 6 |
conceptual framework | 6 |
active pocket | 6 |
investigate whether | 6 |
free water | 6 |
intestinal epithelium | 6 |
virus antigen | 6 |
plasma pool | 6 |
studies showed | 6 |
genome equivalents | 6 |
infection induces | 6 |
polyacrylamide gel | 6 |
goat pbmcs | 6 |
inflammatory cell | 6 |
per group | 6 |
candidate genes | 6 |
essential role | 6 |
higher expression | 6 |
full list | 6 |
pcr kit | 6 |
chicken embryo | 6 |
genomic rna | 6 |
negative mutant | 6 |
healthy calves | 6 |
confocal microscope | 6 |
apical side | 6 |
author information | 6 |
sequence data | 6 |
virus titres | 6 |
antisera raised | 6 |
dotted line | 6 |
vector vaccine | 6 |
severe economic | 6 |
antibody production | 6 |
igg alloantibody | 6 |
virus transmission | 6 |
results also | 6 |
type porcine | 6 |
host community | 6 |
rectal swabs | 6 |
hours post | 6 |
antiviral innate | 6 |
experimental studies | 6 |
next generation | 6 |
first weeks | 6 |
pancreatic necrosis | 6 |
activated protein | 6 |
virus spread | 6 |
chicken cd | 6 |
trained immunity | 6 |
virus genome | 6 |
cell binding | 6 |
phylogenetic analysis | 6 |
different types | 6 |
ns proteins | 6 |
polyanhydride nps | 6 |
oxide synthase | 6 |
response induced | 6 |
higher cytolytic | 6 |
source population | 6 |
quantified using | 6 |
producing animals | 6 |
total splenocytes | 6 |
dna viruses | 6 |
heritable trait | 6 |
gene segments | 6 |
growth rate | 6 |
group calves | 6 |
strains identified | 6 |
oil adjuvant | 6 |
influenza viral | 6 |
strong innate | 6 |
tissue tropism | 6 |
aut pigs | 6 |
bovine mhc | 6 |
south korea | 6 |
data collection | 6 |
dynamic changes | 6 |
highly contagious | 6 |
crfk cells | 6 |
coding sequence | 6 |
endocytic pathway | 6 |
five pigs | 6 |
ali cultures | 6 |
cloacal shedding | 6 |
protein levels | 6 |
initiate internalization | 6 |
seven days | 6 |
invasion rate | 6 |
standard procedures | 6 |
anticoccidial vaccine | 6 |
foster city | 6 |
per sample | 6 |
vitro model | 6 |
mortality rate | 6 |
among suckling | 6 |
enteric infections | 6 |
spf chicken | 6 |
north america | 6 |
passive transfer | 6 |
cellular immunity | 6 |
state university | 6 |
months old | 6 |
fluorescence quenching | 6 |
ifn antagonistic | 6 |
pig industry | 6 |
passive immunity | 6 |
intranasal route | 6 |
attenuated salmonella | 6 |
ii cell | 6 |
probe sets | 6 |
positive cells | 6 |
dnak elisa | 6 |
specific ifn | 6 |
mediated antiviral | 6 |
prv infected | 6 |
white arrows | 6 |
pcr amplification | 6 |
mm mgcl | 6 |
electron microscopy | 6 |
intracellularis organisms | 6 |
activating receptor | 6 |
sense rna | 6 |
serum albumin | 6 |
review see | 6 |
positive correlation | 6 |
indicated concentrations | 6 |
lymphoid tissue | 5 |
fourth transcription | 5 |
viral titration | 5 |
us swine | 5 |
receptor interactions | 5 |
fip lesions | 5 |
human airway | 5 |
neonatal calves | 5 |
cells compared | 5 |
derived significance | 5 |
gene ontology | 5 |
fatty acid | 5 |
viral coinfections | 5 |
southern biotech | 5 |
hi titer | 5 |
relative signal | 5 |
macrophages stimulated | 5 |
reproductive failures | 5 |
considered significant | 5 |
host antiviral | 5 |
freely available | 5 |
mimic mutation | 5 |
also detected | 5 |
nasal discharge | 5 |
two strains | 5 |
natural infection | 5 |
empty shuttle | 5 |
future direction | 5 |
inoculated intranasally | 5 |
exocrine pancreas | 5 |
cropping intensity | 5 |
gene products | 5 |
acid changes | 5 |
basal side | 5 |
antiviral genes | 5 |
toxin production | 5 |
also higher | 5 |
sterile pbs | 5 |
secretory products | 5 |
friedman test | 5 |
internalized pedv | 5 |
significantly changed | 5 |
kegg enrichment | 5 |
heat maps | 5 |
virus detection | 5 |
wild waterfowl | 5 |
animal study | 5 |
domestic poultry | 5 |
strain js | 5 |
prrsv vaccines | 5 |
attenuated vaccines | 5 |
primary prv | 5 |
mutant viruses | 5 |
might play | 5 |
inactivated pedv | 5 |
data show | 5 |
short distance | 5 |
collected samples | 5 |
sybr green | 5 |
goat serum | 5 |
different viral | 5 |
defective particles | 5 |
calves inoculated | 5 |
tomatidine may | 5 |
syndrome coronavirus | 5 |
complemented strain | 5 |
significantly decreased | 5 |
short distances | 5 |
sav shedder | 5 |
ciliary activity | 5 |
infection date | 5 |
salmon salmo | 5 |
immune protection | 5 |
dilution series | 5 |
bronchiolar epithelium | 5 |
perfringens jir | 5 |
field isolates | 5 |
pig population | 5 |
protease activity | 5 |
amplifying cells | 5 |
pbmc samples | 5 |
induce protection | 5 |
ifa assay | 5 |
enteroid culture | 5 |
cscl density | 5 |
animal models | 5 |
whole blood | 5 |
protein sequence | 5 |
indirect elisa | 5 |
west nile | 5 |
values smaller | 5 |
paraffin wax | 5 |
spleen nkp | 5 |
recombinant vaccines | 5 |
seoul national | 5 |
growth factor | 5 |
ethics committee | 5 |
enteritis virus | 5 |
genetic characterization | 5 |
reproductive failure | 5 |
bsc cell | 5 |
based typing | 5 |
bovine tuberculosis | 5 |
live vaccines | 5 |
ja strain | 5 |
species identification | 5 |
reading frames | 5 |
chicken igy | 5 |
significant inhibition | 5 |
expression level | 5 |
previously reported | 5 |
nile virus | 5 |
vsv replicons | 5 |
two main | 5 |
type iii | 5 |
increased risk | 5 |
mixed infection | 5 |
modified eagle | 5 |
iga response | 5 |
upper respiratory | 5 |
bacterial spores | 5 |
ii reverse | 5 |
study demonstrated | 5 |
whole genome | 5 |
pedv vaccine | 5 |
igg groups | 5 |
different letters | 5 |
value lower | 5 |
infectious particles | 5 |
centro nacional | 5 |
i protein | 5 |
th response | 5 |
changes observed | 5 |
mesenteric lymph | 5 |
surface staining | 5 |
mean fluorescent | 5 |
heparinized blood | 5 |
pig sera | 5 |
myocardial degeneration | 5 |
enriched pbmc | 5 |
nucleotide identities | 5 |
avian necrotic | 5 |
gene sequences | 5 |
results obtained | 5 |
animals developed | 5 |
herpesvirus type | 5 |
three days | 5 |
higher virus | 5 |
immediate publication | 5 |
vaccine vectors | 5 |
chicken type | 5 |
cell suspension | 5 |
designed using | 5 |
constant acetylation | 5 |
genome sequencing | 5 |
anticoccidial drugs | 5 |
highest dilution | 5 |
prrsv antigens | 5 |
fluorescent intensity | 5 |
feline cd | 5 |
group mean | 5 |
coronavirus spike | 5 |
shedder introduction | 5 |
gfp infection | 5 |
i viruses | 5 |
natural infections | 5 |
embryo fibroblasts | 5 |
cells induced | 5 |
oral tolerance | 5 |
google scholar | 5 |
recombinant chicken | 5 |
proinflammatory cytokine | 5 |
nested pcr | 5 |
vaccination approach | 5 |
might affect | 5 |
cell immune | 5 |
mediated immunity | 5 |
gii subtype | 5 |
side effects | 5 |
weekly thereafter | 5 |
many countries | 5 |
serum igg | 5 |
genotype viid | 5 |
spore adjuvant | 5 |
reference strains | 5 |
spatial analysis | 5 |
serotypes except | 5 |
animal species | 5 |
viruses associated | 5 |
virulence factors | 5 |
secretory activity | 5 |
laying performance | 5 |
fcov qrt | 5 |
two ptov | 5 |
green monkey | 5 |
less pronounced | 5 |
commercial oil | 5 |
also induced | 5 |
replicon particles | 5 |
acute viral | 5 |
pfu ml | 5 |
cell membrane | 5 |
respiratory symptoms | 5 |
quality control | 5 |
human adenovirus | 5 |
fusion peptide | 5 |
vlps expressing | 5 |
cell growth | 5 |
vp genotype | 5 |
mutant virus | 5 |
vital role | 5 |
mdbk mhc | 5 |
early induction | 5 |
pcr master | 5 |
hematopoietic necrosis | 5 |
study design | 5 |
distantly related | 5 |
day old | 5 |
reverse primer | 5 |
ge healthcare | 5 |
target species | 5 |
virus infected | 5 |
vitro studies | 5 |
results confirmed | 5 |
myc proteins | 5 |
expression changes | 5 |
sequence based | 5 |
viral genomes | 5 |
eagle medium | 5 |
low level | 5 |
week intervals | 5 |
genotype vii | 5 |
avirulent viruses | 5 |
tenfold serial | 5 |
influenza vaccines | 5 |
respiratory dc | 5 |
higher antibody | 5 |
rna replication | 5 |
containing tomatidine | 5 |
virus containing | 5 |
cell death | 5 |
significant economic | 5 |
mwg operon | 5 |
immortalized cells | 5 |
interspecies transmission | 5 |
pedv internalization | 5 |
proteins expressed | 5 |
play important | 5 |
inhibitory effect | 5 |
challenge viruses | 5 |
animal experiment | 5 |
higher amounts | 5 |
detectable antibody | 5 |
among groups | 5 |
phylogenic analysis | 5 |
epidemiological functions | 5 |
national institute | 5 |
mean titers | 5 |
tree star | 5 |
cause disease | 5 |
space constraints | 5 |
strain identified | 5 |
coinfections involving | 5 |
three viral | 5 |
sav co | 5 |
specific qpcr | 5 |
chain variable | 5 |
farm animals | 5 |
seven mabs | 5 |
exact test | 5 |
significantly enriched | 5 |
primary infection | 5 |
immunofluorescence staining | 5 |
thermofisher scientific | 5 |
high mutation | 5 |
apical membrane | 5 |
detected among | 5 |
cdna synthesis | 5 |
animal model | 5 |
quantitative real | 5 |
polymerase complex | 5 |
culture systems | 5 |
cell entry | 5 |
similar pattern | 5 |
spread across | 5 |
inducible gene | 5 |
normal goat | 5 |
layer ducks | 5 |
laiv vaccine | 5 |
syndrome viruses | 5 |
single chain | 5 |
histopathological scores | 5 |
culture supernatant | 5 |
specific binding | 5 |
virus titration | 5 |
several viruses | 5 |
blood vessels | 5 |
adverse effects | 5 |
defence system | 5 |
blood loads | 5 |
contact turkeys | 5 |
respiratory infections | 5 |
african green | 5 |
promising results | 5 |
increased number | 5 |
oncorhynchus mykiss | 5 |
may lead | 5 |
culture infectious | 5 |
obtained using | 5 |
different treatment | 5 |
virus belonging | 5 |
strain gd | 5 |
infection pattern | 5 |
cells overexpressing | 5 |
considered statistically | 5 |
prv controls | 5 |
mycobacterium tuberculosis | 5 |
bronchial lymph | 5 |
lavage fluid | 5 |
mean log | 5 |
tailed simple | 5 |
lower levels | 5 |
dual infections | 5 |
longitudinal study | 5 |
internalization rates | 5 |
plaque assay | 5 |
vaccinia virus | 5 |
changes consistent | 5 |
light chain | 5 |
antibody fragment | 5 |
luciferase reporter | 5 |
vaccines containing | 5 |
basal region | 5 |
dna vaccines | 5 |
biological process | 5 |
single stranded | 5 |
olot strain | 5 |
live poultry | 5 |
infectious hematopoietic | 5 |
isotype control | 5 |
poultry farming | 5 |
key genes | 5 |
calves vaccinated | 5 |
mhf inoculation | 5 |
protection afforded | 5 |
suckling piglets | 5 |
sialic acids | 5 |
intestinal organoids | 5 |
expression vector | 5 |
linear model | 5 |
previous report | 5 |
relatively high | 5 |
high morbidity | 5 |
licensed vaccines | 5 |
dairy calves | 5 |
approximately dpi | 5 |
invading pathogens | 5 |
comparison test | 5 |
full genome | 5 |
pig model | 5 |
five different | 5 |
anthropogenic risk | 5 |
different virus | 5 |
growth medium | 5 |
intestinal mucosa | 5 |
cell monolayer | 5 |
experimental gas | 5 |
seeder pig | 5 |
lung compartment | 5 |
stop codon | 5 |
vivo studies | 5 |
mccoy cells | 5 |
human enteroids | 5 |
differentiated airway | 5 |
parenteral vaccination | 5 |
dependent enhancement | 5 |
takara bio | 5 |
enteric pathogens | 5 |
control fish | 5 |
family member | 5 |
mortality rates | 5 |
prrsv strains | 5 |
acid sequence | 5 |
kidney cell | 5 |
commercial swine | 5 |
hpai virus | 5 |
transit amplifying | 5 |
laying period | 5 |
genome array | 5 |
serially diluted | 5 |
flowjo software | 5 |
log fc | 5 |
molecular biology | 5 |
agricultural fairs | 5 |
final model | 5 |
mitigation strategies | 5 |
necrotic loops | 5 |
high viral | 5 |
effector functions | 5 |
streptococcus suis | 5 |
visualized using | 5 |
rna polymerase | 5 |
nkp cd | 5 |
systemic spread | 5 |
treg frequencies | 5 |
strand cdna | 5 |
wide range | 5 |
target gene | 5 |
virus release | 5 |
targeting cl | 5 |
first time | 5 |
chicken gene | 5 |
using western | 5 |
heparan sulfate | 5 |
adjuvant quila | 5 |
type strains | 5 |
comprising lineage | 5 |
disease following | 5 |
full protection | 5 |
rotavirus strains | 5 |
kegg terms | 5 |
receptor nkp | 5 |
i apmv | 5 |
netb toxin | 5 |
well round | 5 |
domestic animals | 5 |
road networks | 4 |
prime boost | 4 |
different methods | 4 |
higher cd | 4 |
perfect real | 4 |
transforming growth | 4 |
available vaccines | 4 |
maternal alloantibodies | 4 |
assay showed | 4 |
time reverse | 4 |
structural basis | 4 |
single infected | 4 |
mouse enteroid | 4 |
major role | 4 |
necrotizing bronchiolitis | 4 |
enterotoxigenic escherichia | 4 |
selector tool | 4 |
duck flocks | 4 |
genome assembly | 4 |
lung epithelial | 4 |
population density | 4 |
cycle arrest | 4 |
given ecosystem | 4 |
infection experiments | 4 |
thank dr | 4 |
chronic infections | 4 |
ha protein | 4 |
log number | 4 |
cd foxp | 4 |
data generated | 4 |
body weights | 4 |
tissue sections | 4 |
animals analysed | 4 |
bacterial colonization | 4 |
confirmed negative | 4 |
units per | 4 |
gp gene | 4 |
prrsv vlps | 4 |
control loops | 4 |
well established | 4 |
enteric disease | 4 |
technical support | 4 |
group denote | 4 |
environmental factors | 4 |
tomatidine treatment | 4 |
host complex | 4 |
different values | 4 |
internalized virions | 4 |
subclinical infections | 4 |
od values | 4 |
mannheimia haemolytica | 4 |
protein level | 4 |
human pathogens | 4 |
old spf | 4 |
well known | 4 |
human vaccine | 4 |
chickens administered | 4 |
losses worldwide | 4 |
embryo fibroblast | 4 |
vector laboratories | 4 |
domestic waterfowl | 4 |
four replicates | 4 |
comparative analysis | 4 |
related viruses | 4 |
pedv variant | 4 |
prv shedders | 4 |
hcesps significantly | 4 |
viral components | 4 |
extracted using | 4 |
like strain | 4 |
entry relies | 4 |
oxidative stress | 4 |
teer values | 4 |
per animal | 4 |
animal facility | 4 |
dnak antibodies | 4 |
strain gds | 4 |
rna detected | 4 |
following standard | 4 |
vaccine controls | 4 |
none group | 4 |
target tissues | 4 |
i fcov | 4 |
receptor family | 4 |
restriction sites | 4 |
similar levels | 4 |
dnak antibody | 4 |
swine virus | 4 |
hamster model | 4 |
cytokine responses | 4 |
faecal extract | 4 |
expression pattern | 4 |
experimental design | 4 |
abi prism | 4 |
severe respiratory | 4 |
vascular permeability | 4 |
akt pkb | 4 |
annexinv aad | 4 |
generated using | 4 |
plots describes | 4 |
raw counts | 4 |
step rrt | 4 |
ifn response | 4 |
culture plates | 4 |
tracheobronchial lymph | 4 |
also confirmed | 4 |
field strains | 4 |
neutralization assay | 4 |
specific network | 4 |
reference genome | 4 |
via mhc | 4 |
oropharyngeal swabs | 4 |
cells remains | 4 |
viral genes | 4 |
study also | 4 |
current vaccines | 4 |
acetylation modification | 4 |
mucosal vaccine | 4 |
gp protein | 4 |
virus internalization | 4 |
encephalitis virus | 4 |
genes involved | 4 |
may play | 4 |
urate deposition | 4 |
virus replicates | 4 |
tandem mass | 4 |
tool helps | 4 |
myeloid cells | 4 |
illumina hiseq | 4 |
subset compared | 4 |
distance spread | 4 |
interfering influenza | 4 |
infection experiment | 4 |
isolated using | 4 |
early infection | 4 |
bottom plates | 4 |
liaison host | 4 |
rna helicase | 4 |
estimating fifty | 4 |
enrichment analysis | 4 |
finish farm | 4 |
interacting proteins | 4 |
virus isolate | 4 |
world organisation | 4 |
sav compared | 4 |
functional antibody | 4 |
oviduct cysts | 4 |
intervention strategies | 4 |
bird species | 4 |
treated groups | 4 |
receptor interaction | 4 |
different vaccine | 4 |
rabbit igg | 4 |
ns expression | 4 |
strong correlation | 4 |
serine threonine | 4 |
pedv utilized | 4 |
second round | 4 |
amplification cycles | 4 |
significant go | 4 |
disease transmission | 4 |
human populations | 4 |
viral genomic | 4 |
member cd | 4 |
emissions every | 4 |
using specific | 4 |
viral respiratory | 4 |
step rt | 4 |
enteric form | 4 |
old specific | 4 |
laboratories inc | 4 |
defined haplotypes | 4 |
novel vaccine | 4 |
cell tropism | 4 |
spore vaccines | 4 |
choose bmc | 4 |
rm infected | 4 |
horizontal line | 4 |
performed according | 4 |
severe influenza | 4 |
nm excitation | 4 |
positive selection | 4 |
treated purified | 4 |
two independent | 4 |
strain jir | 4 |
intestinal loops | 4 |
es products | 4 |
high mortality | 4 |
relevant journal | 4 |
later stages | 4 |
virulent form | 4 |
protective role | 4 |
isolated pbmc | 4 |
hemoplasma infections | 4 |
pathogen interactions | 4 |
prrsv challenge | 4 |
delivery system | 4 |
slightly lower | 4 |
heat inactivated | 4 |
different mechanisms | 4 |
slightly higher | 4 |
various cytokines | 4 |
viral populations | 4 |
protein differences | 4 |
virus attachment | 4 |
amongst others | 4 |
protein concentration | 4 |
within macrophages | 4 |
delivery platforms | 4 |
nonstructural protein | 4 |
significance level | 4 |
two days | 4 |
associated lymphoid | 4 |
negative correlation | 4 |
also demonstrated | 4 |
kegg pathways | 4 |
white blood | 4 |
kul monocytes | 4 |
velogenic newcastle | 4 |
foreign antigens | 4 |
confocal fluorescence | 4 |
mock infected | 4 |
closest highway | 4 |
experimentally challenged | 4 |
expression patterns | 4 |
cytokine chemokine | 4 |
chicken interferome | 4 |
horizontal dotted | 4 |
following infection | 4 |
three tissues | 4 |
prrsv strain | 4 |
bacillus spores | 4 |
remaining pigs | 4 |
pulmonary intravascular | 4 |
study found | 4 |
pig herds | 4 |
linear regression | 4 |
cloaca swabs | 4 |
host restriction | 4 |
scfv library | 4 |
multivalent vaccine | 4 |
response compared | 4 |
accept pre | 4 |
hi activity | 4 |
epidemiological study | 4 |
fibrin microthrombi | 4 |
management practices | 4 |
significantly suppressed | 4 |
perfringens virulence | 4 |
inoculated birds | 4 |
showed similar | 4 |
histopathological scoring | 4 |
anatomic compartments | 4 |
induced endothelial | 4 |
delivery strategies | 4 |
lipid metabolism | 4 |
neutralizing epitopes | 4 |
analysis showed | 4 |
transmission pathways | 4 |
iav positive | 4 |
hemagglutinating encephalomyelitis | 4 |
degranulation assays | 4 |
cells ml | 4 |
completely inhibited | 4 |
antiviral immune | 4 |
outer capsid | 4 |
mucosal surfaces | 4 |
close collaboration | 4 |
antigen staining | 4 |
gastrointestinal tract | 4 |
high variability | 4 |
laiv groups | 4 |
gross lung | 4 |
sera obtained | 4 |
evidence suggests | 4 |
antigen delivery | 4 |
atcc vr | 4 |
iav rna | 4 |
luciferase activities | 4 |
rna interference | 4 |
japanese encephalitis | 4 |
first report | 4 |
authors concluded | 4 |
experimental period | 4 |
cd bright | 4 |
immune escape | 4 |
day follow | 4 |
harderian gland | 4 |
hi antibody | 4 |
stem cells | 4 |
canine kidney | 4 |
one day | 4 |
comprehensive review | 4 |
study showed | 4 |
genetic background | 4 |
polyclonal antibody | 4 |
challenge strain | 4 |
much higher | 4 |
measles virus | 4 |
results suggested | 4 |
empty vector | 4 |
untreated tadv | 4 |
purified recombinant | 4 |
including influenza | 4 |
strains detected | 4 |
average daily | 4 |
adhesion molecules | 4 |
chronic infection | 4 |
liposome nps | 4 |
cytokines locally | 4 |
two separate | 4 |
will help | 4 |
santa clara | 4 |
pigs following | 4 |
serum neutralization | 4 |
cellular factors | 4 |
second pcr | 4 |
clinical manifestations | 4 |
humidified chamber | 4 |
control calves | 4 |
interfering virus | 4 |
molecular mechanisms | 4 |
stranded positive | 4 |
sav infected | 4 |
highest serum | 4 |
important diseases | 4 |
following homologous | 4 |
molecular dynamics | 4 |
microarray analysis | 4 |
virus detected | 4 |
endocytosis pathways | 4 |
dna vaccine | 4 |
strain rm | 4 |
qpcr assays | 4 |
glycoproteins gp | 4 |
rapid detection | 4 |
enhanced replication | 4 |
cytolytic capacity | 4 |
cellular dna | 4 |
water ad | 4 |
cells expressing | 4 |
excellent technical | 4 |
remained within | 4 |
vaccine induces | 4 |
cells produced | 4 |
groups remained | 4 |
peripheral immune | 4 |
rank correlation | 4 |
furin cleavage | 4 |
new insights | 4 |
hosts may | 4 |
data points | 4 |
heterologous antigens | 4 |
young pigs | 4 |
inactivated foetal | 4 |
host system | 4 |
data interpretation | 4 |
data obtained | 4 |
data analyses | 4 |
transcriptase polymerase | 4 |
innate cytokines | 4 |
fiber protein | 4 |
infectious agent | 4 |
elisa kit | 4 |
antigenic sites | 4 |
fmdv immune | 4 |
industry worldwide | 4 |
liquid interface | 4 |
enveloped virus | 4 |
antigen expression | 4 |
cytokine secretion | 4 |
recombinant porcine | 4 |
expression plasmids | 4 |
sequences detected | 4 |
pcr primers | 4 |
cpg oligodeoxynucleotide | 4 |
control iav | 4 |
operational framework | 4 |
also associated | 4 |
molecular docking | 4 |
cytokines chemokines | 4 |
induced higher | 4 |
sequencing primer | 4 |
colored green | 4 |
cell membranes | 4 |
south china | 4 |
mrna level | 4 |
using chicken | 4 |
studies demonstrated | 4 |
bronchial bronchiolar | 4 |
mhf bacteremia | 4 |
affected animals | 4 |
positive controls | 4 |
cap protein | 4 |
higher numbers | 4 |
vice versa | 4 |
study revealed | 4 |
seropositive pigs | 4 |
also provide | 4 |
cryptosporidium isolates | 4 |
ptov strain | 4 |
nasal cavities | 4 |
inhibited pedv | 4 |
detected using | 4 |
software inc | 4 |
alphavirus subtype | 4 |
species transmission | 4 |
human coronavirus | 4 |
feline immunodeficiency | 4 |
exact role | 4 |
monocyte counts | 4 |
challenge experiment | 4 |
rabbit antiserum | 4 |
factors involved | 4 |
reaction buffer | 4 |
vaccine components | 4 |
plaque reduction | 4 |
based proteomic | 4 |
permeabilization buffer | 4 |
endocytic vesicles | 4 |
using real | 4 |
first pathogen | 4 |
vitro stimulation | 4 |
university institutional | 4 |
may reduce | 4 |
zoonotic potential | 4 |
vp fragment | 4 |
attenuated virus | 4 |
vaccine formulation | 4 |
serotype ii | 4 |
lineage i | 4 |
fresh medium | 4 |
anas platyrhynchos | 4 |
related deg | 4 |
vaccine group | 4 |
every minute | 4 |
receptor involved | 4 |
constructed using | 4 |
innate response | 4 |
kg day | 4 |
initiate infection | 4 |
protein complex | 4 |
regulatory factor | 4 |
perfringens antigens | 4 |
laiv treatment | 4 |
pcr reactions | 4 |
apoptosis via | 4 |
group remained | 4 |
significantly fewer | 4 |
virus pathogenesis | 4 |
different subsets | 4 |
pathogenic variant | 4 |
induces apoptosis | 4 |
neutralizing activity | 4 |
specific cd | 4 |
three main | 4 |
epidemiological function | 4 |
broad range | 4 |
elevated levels | 4 |
possible explanation | 4 |
bnp calf | 4 |
novel adjuvants | 4 |
chick embryo | 4 |
ethical committee | 4 |
alveolar macrophage | 4 |
submission inquiries | 4 |
disease outbreaks | 4 |
partially protects | 4 |
ebola virus | 4 |
protein sequences | 4 |
road network | 4 |
subcellular localization | 4 |
selplg gene | 4 |
culture adapted | 4 |
tested mhf | 4 |
production system | 4 |
molecular probes | 4 |
milk replacer | 4 |
southern biotechnology | 4 |
interferon production | 4 |
purified using | 4 |
mild respiratory | 4 |
secreting cell | 4 |
encephalomyelitis virus | 4 |
often used | 4 |
associated protein | 4 |
early immune | 4 |
end point | 4 |
nkp defined | 4 |
least three | 4 |
showed significantly | 4 |
negative binomial | 4 |
lesser extent | 4 |
plga nanoparticles | 4 |
overall average | 4 |
next page | 4 |
pathogenicity avian | 4 |
effective vaccine | 4 |
conventional dendritic | 4 |
yangzhou university | 4 |
fast equipment | 4 |
immune cell | 4 |
experimental challenge | 4 |
method using | 4 |
iga levels | 4 |
vaccine formulations | 4 |
iav vaccines | 4 |
prv challenge | 4 |
strains within | 4 |
single infections | 4 |
maintenance population | 4 |
pigs per | 4 |
line depicts | 4 |
enteric coronaviruses | 4 |
severe clinical | 4 |
fixed samples | 4 |
serovar typhimurium | 4 |
natural products | 4 |
eimeria tenella | 4 |
mini kit | 4 |
vaccine administered | 4 |
vaccinated intramuscularly | 4 |
mucosal adjuvant | 4 |
ribonucleic acid | 4 |
ucd infected | 4 |
gst tag | 4 |
retinoic acid | 4 |
cytokines il | 4 |
acid residues | 4 |
single cells | 4 |
one sample | 4 |
thermal profile | 4 |
mouse rbc | 4 |
host range | 4 |
viral titer | 4 |
bordetella bronchiseptica | 4 |
virusinfected group | 4 |
sorted nk | 4 |
sequencing kit | 4 |
rank test | 4 |
sea water | 4 |
gross pathology | 4 |
gsea results | 4 |
isolation kit | 4 |
i interferons | 4 |
viral structural | 4 |
time quantitative | 4 |
epizootic swine | 4 |
high heritability | 4 |
associated markers | 4 |
infection induced | 4 |
i card | 4 |
showed high | 4 |
processed using | 4 |
washing steps | 4 |
field serum | 4 |
weaned pigs | 4 |
mhf blood | 4 |
host competence | 4 |
strain ucd | 4 |
production parameters | 4 |
agents associated | 4 |
fowlpox virus | 4 |
heterologous laiv | 4 |
manuscript revision | 4 |
forming units | 4 |
still unclear | 4 |
swine herds | 4 |
hemotropic mycoplasma | 4 |
fold serial | 4 |
inflammatory cells | 4 |
group contained | 4 |
vaccine platforms | 4 |
gradient purified | 4 |
four weeks | 4 |